| Dhivya Kuzhandai Velu, MD | |
|
101 Sivley Rd Sw, Huntsville, AL 35801-4421 | |
| (256) 265-1000 | |
| Not Available |
| Full Name | Dhivya Kuzhandai Velu |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 101 Sivley Rd Sw, Huntsville, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972165355 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD46994 (Alabama) | Primary |
| 207R00000X | Internal Medicine | MD46994 (Alabama) | Secondary |
| Entity Name | Hh Physician Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144860123 PECOS PAC ID: 4082042940 Enrollment ID: O20200309000744 |
News Archive
A new immunotherapy screening prototype developed by University of California, Irvine researchers can quickly create individualized cancer treatments that will allow physicians to effectively target tumors without the side effects of standard cancer drugs.
Agalimmune Ltd, a biopharmaceutical company, has been created to develop innovative immunotherapeutics for the treatment of cancer, with a focus on solid tumours.
According to a major report by 41 leading scientists, health-policy experts and economists, the world could be free of malaria by 2050.
The surgical removal of the appendix and tonsils before the age of 20 was associated with an increased risk of premature heart attack in a large population study performed in Sweden. Tonsillectomy increased the risk by 44% (hazard ratio 1.44) and appendectomy by 33% (HR 1.33).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dhivya Kuzhandai Velu, MD 101 Sivley Rd Sw, Huntsville, AL 35801-4470 Ph: (256) 265-1000 | Dhivya Kuzhandai Velu, MD 101 Sivley Rd Sw, Huntsville, AL 35801-4421 Ph: (256) 265-1000 |
News Archive
A new immunotherapy screening prototype developed by University of California, Irvine researchers can quickly create individualized cancer treatments that will allow physicians to effectively target tumors without the side effects of standard cancer drugs.
Agalimmune Ltd, a biopharmaceutical company, has been created to develop innovative immunotherapeutics for the treatment of cancer, with a focus on solid tumours.
According to a major report by 41 leading scientists, health-policy experts and economists, the world could be free of malaria by 2050.
The surgical removal of the appendix and tonsils before the age of 20 was associated with an increased risk of premature heart attack in a large population study performed in Sweden. Tonsillectomy increased the risk by 44% (hazard ratio 1.44) and appendectomy by 33% (HR 1.33).
› Verified 6 days ago
Kimberly Tarver, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 245 Governors Dr Se, Huntsville, AL 35801 Phone: 256-265-1198 | |
Liesl Pavlic, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 101 Sivley Rd Sw, Huntsville, AL 35801 Phone: 256-801-6047 Fax: 256-801-6218 | |
Amber Noelle Shiflet, CRNP Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 101 Sivley Rd Sw, Huntsville, AL 35801 Phone: 256-265-1000 | |
Larissa Mueller Pierce, MA, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 101 Sivley Rd Sw, Huntsville, AL 35801 Phone: 256-265-3880 Fax: 256-265-3886 | |
Dr. Lorie Glover Dawson, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 115 Manning Dr Sw Ste A101, Huntsville, AL 35801 Phone: 256-533-1030 Fax: 256-533-1043 | |
Sukhmanpreet Singh, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 101 Sivley Rd Sw, Huntsville, AL 35801 Phone: 256-265-3880 Fax: 256-265-3886 | |
Hicham Azzouzi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 101 Sivley Rd Sw, Huntsville, AL 35801 Phone: 256-265-3880 Fax: 256-265-3886 |